Under the advisement of the U.S. Food & Drug Administration, Biostage has decided to extend their animal testing of its Cellframe organ implants and push back its investigational new drug (IND) filing.
The state Department of Public Health has recommended approval of a $1 billion expansion at Boston Children's Hospital, a step that moves the controversial project closer to fruition.
Worcester-based Compassionate Homecare and three individuals have been indicted in connection with allegations that they stole hundreds of thousands of dollars from the state's Medicaid program.
Agilux Laboratories has been acquired by Charles River Laboratories International, a move that will allow the Wilmington company to begin working with clients earlier in the drug research process.
The board of UMass Memorial Health Care has voted for a merger between its hospitals in Clinton and Leominster, with a final decision from the state to come within the next six months.